Conversion of a molecular classifier obtained by gene expression profiling into a classifier based on real-time PCR: a prognosis predictor for gliomas
暂无分享,去创建一个
N. Hashimoto | S. Miyamoto | Y. Kukita | M. Shirahata | J. Takahashi | Kikuya Kato | K. Taniguchi | N. Mikuni | S. Kawarazaki | Manabu Kanemoto
[1] G. Reifenberger,et al. NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] O. Van Wuytswinkel,et al. Normalization of qRT-PCR data: the necessity of adopting a systematic, experimental conditions-specific, validation of references. , 2009, Journal of experimental botany.
[3] S. Ishii,et al. Using gene expression profiling to identify a prognostic molecular spectrum in gliomas , 2008, Cancer science.
[4] S. Paik. Development and clinical utility of a 21-gene recurrence score prognostic assay in patients with early breast cancer treated with tamoxifen. , 2007, The oncologist.
[5] Catalin C. Barbacioru,et al. Effect of various normalization methods on Applied Biosystems expression array system data , 2006, BMC Bioinformatics.
[6] A. Witteveen,et al. Converting a breast cancer microarray signature into a high-throughput diagnostic test , 2006, BMC Genomics.
[7] M. Ishikawa,et al. Phase II study of nimustine, carboplatin, vincristine, and interferon-beta with radiotherapy for glioblastoma multiforme: experience of the Kyoto Neuro-Oncology Group. , 2006, Journal of neurosurgery.
[8] Lu Zhang,et al. Large scale real-time PCR validation on gene expression measurements from two commercial long-oligonucleotide microarrays , 2006, BMC Genomics.
[9] M. Piérart,et al. Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial , 2005, The Lancet.
[10] S. Ishii,et al. Adaptor-tagged competitive polymerase chain reaction: amplification bias and quantified gene expression levels. , 2005, Analytical biochemistry.
[11] M. Cronin,et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. , 2004, The New England journal of medicine.
[12] Claus Lindbjerg Andersen,et al. Normalization of Real-Time Quantitative Reverse Transcription-PCR Data: A Model-Based Variance Estimation Approach to Identify Genes Suited for Normalization, Applied to Bladder and Colon Cancer Data Sets , 2004, Cancer Research.
[13] F. Speleman,et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.
[14] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[15] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[16] Kikuya Kato,et al. Adaptor-tagged competitive PCR: a novel method for measuring relative gene expression. , 1997, Nucleic acids research.
[17] D K Pearl,et al. Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas , 1997, Cancer.
[18] Ronald W. Davis,et al. Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray , 1995, Science.
[19] Chi-Ying F. Huang,et al. BMC Genomics BioMed Central Methodology article , 2008 .